Evidence map›Paper›PMID 25578653›Full record

ArticleFree radical biology & medicine2015

CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection.

Cuihong Jin, Lili Qin, Yan Shi, Demet Candas, Ming Fan, Chung-Ling Lu, Andrew T M Vaughan, Rulong Shen, Larry S Wu, Rui Liu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. COVID-19 and low-dose radiation therapy.Radiation medicine and protection · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Insights into the Dichotomous Regulation of SOD2 in Cancer.Antioxidants (Basel, Switzerland) · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Cuihong JinDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Lili QinDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Yan ShiDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Demet CandasDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Ming FanDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Chung-Ling LuDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Andrew T M VaughanDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Rulong ShenDepartment of Pathology, Ohio State University Medical College, Columbus, OH 43210, USA.
Larry S WuDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Rui LiuDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Robert F LiDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
Jeffrey S MurleyDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA.
Gayle WoloschakDepartment of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
David J GrdinaDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA.
Jian Jian LiDepartment of Radiation Oncology, University of California at Davis School of Medicine, Sacramento, CA 95817, USA; NCI-Designated Comprehensive Cancer Center, University of California at Davis Health System, Sacramento, CA, 95817, USA. Electronic address: jijli@ucdavis.edu.
University of California, Davis · USUniversity of Chicago · USNorthwestern University · USThe Ohio State University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Target MKP-1 for Therapy-Resistant Breast Cancer Stem CellsR01CA152313 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LI, JIAN JIAN · 2011 to 2015
$1.9M
NCI NIH HHS CA152313NCI NIH HHS P30 CA060553NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA152313
6 · The paper itself

Abstract

Mammalian cells are able to sense environmental oxidative and genotoxic conditions such as the environmental low-dose ionizing radiation (LDIR) present naturally on the earth's surface. The stressed cells then can induce a so-called radioadaptive response with an enhanced cellular homeostasis and repair capacity against subsequent similar genotoxic conditions such as a high dose radiation. Manganese superoxide dismutase (MnSOD), a primary mitochondrial antioxidant in mammals, has long been known to play a crucial role in radioadaptive protection by detoxifying O2(•-) generated by mitochondrial oxidative phosphorylation. In contrast to the well-studied mechanisms of SOD2 gene regulation, the mechanisms underlying posttranslational regulation of MnSOD for radioprotection remain to be defined. Herein, we demonstrate that cyclin D1/cyclin-dependent kinase 4 (CDK4) serves as the messenger to deliver the stress signal to mitochondria to boost mitochondrial homeostasis in human skin keratinocytes under LDIR-adaptive radioprotection. Cyclin D1/CDK4 relocates to mitochondria at the same time as MnSOD enzymatic activation peaks without significant changes in total MnSOD protein level. The mitochondrial-localized CDK4 directly phosphorylates MnSOD at serine-106 (S106), causing enhanced MnSOD enzymatic activity and mitochondrial respiration. Expression of mitochondria-targeted dominant negative CDK4 or the MnSOD-S106 mutant reverses LDIR-induced mitochondrial enhancement and adaptive protection. The CDK4-mediated MnSOD activation and mitochondrial metabolism boost are also detected in skin tissues of mice receiving in vivo whole-body LDIR. These results demonstrate a unique CDK4-mediated mitochondrial communication that allows cells to sense environmental genotoxic stress and boost mitochondrial homeostasis by enhancing phosphorylation and activation of MnSOD.

Indexed as

Adaptation, PhysiologicalAnimalsCell LineCyclin D1Cyclin-Dependent Kinase 4Dose-Response Relationship, RadiationGene Expression RegulationHumansKeratinocytesMembrane Potential, MitochondrialMiceMice, Inbred BALB CMitochondriaOxidative PhosphorylationPhosphorylationRadiation, IonizingCcnd1 protein, mouseCdk4 protein, mouseCyclin D1Cyclin-Dependent Kinase 4Superoxide DismutaseCyclin D1/CDK4Free radicalsMitochondrial homeostasisMnSODPhosphorylationRadioadaptive response

Identifiers

PMID25578653
PMCPMC4359946
OpenAlexW2078105679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.